GYS1
Glycogen [starch] synthase, muscle
Also known as: GSY, GYS, GYS1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13807
- Gene
- GYS1
- Ensembl
- ENSG00000104812
- Chromosome
- 19
- Canonical length
- 737 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytosol
OverviewNCBI Gene
The protein encoded by this gene catalyzes the addition of glucose monomers to the growing glycogen molecule through the formation of alpha-1,4-glycoside linkages. Mutations in this gene are associated with muscle glycogen storage disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
Canonical amino-acid sequenceUniProt
737 residues, UniProt reviewed canonical sequence.
>P13807|GYS1
1 MPLNRTLSMS SLPGLEDWED EFDLENAVLF EVAWEVANKV GGIYTVLQTK AKVTGDEWGD
61 NYFLVGPYTE QGVRTQVELL EAPTPALKRT LDSMNSKGCK VYFGRWLIEG GPLVVLLDVG
121 ASAWALERWK GELWDTCNIG VPWYDREAND AVLFGFLTTW FLGEFLAQSE EKPHVVAHFH
181 EWLAGVGLCL CRARRLPVAT IFTTHATLLG RYLCAGAVDF YNNLENFNVD KEAGERQIYH
241 RYCMERAAAH CAHVFTTVSQ ITAIEAQHLL KRKPDIVTPN GLNVKKFSAM HEFQNLHAQS
301 KARIQEFVRG HFYGHLDFNL DKTLYFFIAG RYEFSNKGAD VFLEALARLN YLLRVNGSEQ
361 TVVAFFIMPA RTNNFNVETL KGQAVRKQLW DTANTVKEKF GRKLYESLLV GSLPDMNKML
421 DKEDFTMMKR AIFATQRQSF PPVCTHNMLD DSSDPILTTI RRIGLFNSSA DRVKVIFHPE
481 FLSSTSPLLP VDYEEFVRGC HLGVFPSYYE PWGYTPAECT VMGIPSISTN LSGFGCFMEE
541 HIADPSAYGI YILDRRFRSL DDSCSQLTSF LYSFCQQSRR QRIIQRNRTE RLSDLLDWKY
601 LGRYYMSARH MALSKAFPEH FTYEPNEADA AQGYRYPRPA SVPPSPSLSR HSSPHQSEDE
661 EDPRNGPLEE DGERYDEDEE AAKDRRNIRA PEWPRRASCT SSTSGSKRNS VDTATSSSLS
721 TPSEPLSPTS SLGEERNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GYS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 299 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 299 nTPM
- tongue: 188 nTPM
- heart muscle: 112 nTPM
- bone marrow: 44 nTPM
- esophagus: 37 nTPM
- adipose tissue: 31 nTPM
Single-cell type
- myonuclei: 323 nCPM
- neutrophil progenitors: 200 nCPM
- cone photoreceptor cells: 162 nCPM
- rod photoreceptor cells: 96 nCPM
- prostatic hillock cells: 75 nCPM
- adipocytes: 74 nCPM
Immune cell
- myeloid DC: 13 nTPM
- NK-cell: 11 nTPM
- classical monocyte: 9.4 nTPM
- MAIT T-cell: 8.6 nTPM
- T-reg: 8.6 nTPM
- non-classical monocyte: 8.1 nTPM
Brain region
- cerebellum: 46 nTPM
- cerebral cortex: 41 nTPM
- medulla oblongata: 39 nTPM
- choroid plexus: 39 nTPM
- midbrain: 36 nTPM
- thalamus: 35 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GYS1.
Disease | AllUniProt
Conditions GYS1 is implicated in, by any mechanism.
- Muscle glycogen storage disease 0 (GSD0b) MIM:611556
Disease | GeneticClinVar
43 pathogenic / likely-pathogenic of 756 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Glycogen storage disease due to muscle and heart glycogen synthase deficiency
- GYS1-related disorder
- Glycogen storage disease
- Fetal akinesia deformation sequence 3
- Congenital myasthenic syndrome 10
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.84
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity
- D-glucose binding
- glycogen synthase activity, transferring glucose-1-phosphate
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GYS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GYS1 as an antibody target. Whether an autoantibody or antibody against GYS1 could matter depends on whether native GYS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GYS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GYS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...